Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 1/20 | 0.38 |
| ▸ | CCKBR | P32239 | 3/20 | 0.38 |
| ▸ | CTSL | P07711 | 3/20 | 0.37 |
| ▸ | CTSS | P25774 | 3/20 | 0.37 |
| ▸ | CTSK | P43235 | 3/20 | 0.37 |
| ▸ | CTSH | P09668 | 1/20 | 0.37 |
| ▸ | GRPR | P30550 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12045120 | 0.91 | REN (0.41) | RENCTSLCTSSCTSKCTSH | |
| SCHEMBL30999518 | 0.84 | CCKBR (0.46) | CCKBR | |
| SCHEMBL30074450 | 0.83 | REN (0.37) | RENCCKBR | |
| SCHEMBL30999648 | 0.83 | CCKBR (0.62) | CCKBR | |
| SCHEMBL27624719 | 0.83 | MMP7 (0.38) | RENGRPR | |
| SCHEMBL31157683 | 0.83 | CTSL (0.51) | CCKBRCTSLCTSSCTSKCTSH | |
| SCHEMBL11759100 | 0.82 | REN (0.54) | RENCTSLCTSSCTSK | |
| SCHEMBL11765581 | 0.82 | REN (0.54) | RENCTSLCTSSCTSK | |
| SCHEMBL12972180 | 0.82 | MMP7 (0.38) | RENGRPR | |
| SCHEMBL16507899 | 0.81 | PTPN1 (0.44) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110294738-A1 | PTHR1 RECEPTOR COMPOUNDS | ANTHOR THERAPEUTICS, INC. | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294738-A1 | PTHR1 RECEPTOR COMPOUNDS | PTH1R, MC1R, CASR | REN 525/4885CCKBR 1309/4885CTSL 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.